BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6201871)

  • 21. [Pathogenesis and norsteroid treatment of bladder neck adenoma (prostatic hypertrophy)].
    Magyarsóky F
    Acta Chir Acad Sci Hung; 1973 Aug; 14(3):209-22. PubMed ID: 4129777
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of the "prostate test" in checking the administration of oestrogens in the calf.
    Ruitenberg EJ; Kroes R; Berkvens J
    Zentralbl Veterinarmed A; 1970 Apr; 17(4):351-7. PubMed ID: 4192358
    [No Abstract]   [Full Text] [Related]  

  • 23. A new mouse model for prostatic hyperplasia: induction of adult prostatic overgrowth by fetal urogenital sinus implants.
    Chung LW; Matsuura J; Rocco AK; Thompson TC; Miller GJ; Runner MN
    Prog Clin Biol Res; 1984; 145():291-306. PubMed ID: 6201880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostatic growth: new insights into hormonal regulation.
    McConnell JD
    Br J Urol; 1995 Jul; 76 Suppl 1():5-10. PubMed ID: 7544215
    [No Abstract]   [Full Text] [Related]  

  • 25. [Relation between benign prostatic hyperplasia and obesity and estrogen].
    Matsuda T; Abe H; Suda K
    Rinsho Byori; 2004 Apr; 52(4):291-4. PubMed ID: 15164594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pressure effects on cellular systems: is there a link with benign prostatic hyperplasia?
    Hegarty P; Watson RW; Hegarty NJ; Coffey RN; Fitzpatrick JM
    Urology; 2004 Aug; 64(2):195-200. PubMed ID: 15302460
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of long-term administration of androgens and estrogen on rhesus monkey prostate: possible induction of benign prostatic hyperplasia.
    Jeyaraj DA; Udayakumar TS; Rajalakshmi M; Pal PC; Sharma RS
    J Androl; 2000; 21(6):833-41. PubMed ID: 11105909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of hormonal factors in the pathogenesis of prostatic hypertrophy].
    Baranowska B; Migdalska B; Szymanowski J; Kozłowicz I
    Pol Tyg Lek; 1977 Feb; 32(6):251-3. PubMed ID: 65771
    [No Abstract]   [Full Text] [Related]  

  • 29. Pathogenesis of benign prostatic hyperplasia.
    Bosch RJ
    Eur Urol; 1991; 20 Suppl 1():27-30. PubMed ID: 1722157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conference summary on prostate growth and aging, 13-15 September 2000.
    Brown TR; Lee C
    Prostate; 2001 Jun; 48(1):54-65. PubMed ID: 11391687
    [No Abstract]   [Full Text] [Related]  

  • 31. [Epidemiology and natural history of benign prostatic hyperplasia].
    Sugimura Y
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():318-21. PubMed ID: 12599592
    [No Abstract]   [Full Text] [Related]  

  • 32. Developmental estrogenization and prostatic neoplasia.
    Santti R; Newbold RR; Mäkelä S; Pylkkänen L; McLachlan JA
    Prostate; 1994; 24(2):67-78. PubMed ID: 7508622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benign prostatic hyperplasia due to venous drainage malfunction in the male reproductive system: a price of erect posture in humans.
    Schill WB; Ben-Shlomo I
    Andrologia; 2008 Oct; 40(5):272. PubMed ID: 18811915
    [No Abstract]   [Full Text] [Related]  

  • 34. The pathogenesis of benign prostatic hyperplasia.
    Wilson JD
    Am J Med; 1980 May; 68(5):745-56. PubMed ID: 6155068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Androgen sensitivity of prostate epithelium is enhanced by postnatal androgen receptor inactivation.
    Simanainen U; McNamara K; Gao YR; Handelsman DJ
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1335-43. PubMed ID: 19366880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in the effects of estradiol on dihydrotestosterone induced prostatic growth of the castrate dog and rat.
    Ehrlichman RJ; Isaacs JT; Coffey DS
    Invest Urol; 1981 May; 18(8):466-70. PubMed ID: 7228581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Etiopathogenesis of benign prostatic hypertrophy].
    Montanari E; Guarneri A; Dell'Orto P; Gelosa M
    Arch Ital Urol Androl; 1995 Feb; 67(1):7-12. PubMed ID: 7538393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Some aspects of the pathogenesis of prostatic hyperplasia.
    Tveter KJ
    Acta Pathol Microbiol Scand Suppl; 1974; Suppl 248():167-74. PubMed ID: 4141576
    [No Abstract]   [Full Text] [Related]  

  • 39. [Role of the prostatic capsule in the physiopathology of benign prostatic hypertrophy].
    Sattar AA; Caufriez M; Wespes E; Noël JC; Schulman CC
    Acta Urol Belg; 1994 Sep; 62(3):43-6. PubMed ID: 7526669
    [No Abstract]   [Full Text] [Related]  

  • 40. Pathology of benign prostatic hyperplasia.
    Roehrborn CG
    Int J Impot Res; 2008 Dec; 20 Suppl 3():S11-8. PubMed ID: 19002119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.